We have 19 prostate cancer PhD Projects, Programmes & Scholarships

Discipline

Discipline

All disciplines

Location

Location

All locations

Institution

Institution

All Institutions

PhD Type

PhD Type

All PhD Types

Funding

Funding

All Funding


prostate cancer PhD Projects, Programmes & Scholarships

We have 19 prostate cancer PhD Projects, Programmes & Scholarships

Targeting the MAPK scaffold protein KSR1 for the treatment of prostate cancer

  Research Group: Institute of Cancer Therapeutics
Prostate cancer is one of the leading causes of male cancer deaths. It arises when individual cells escape their normal growth control mechanisms and proliferate in an uncontrolled fashion. Read more

Identifying DNA methylation signatures of prostate cancer progression and mortality among patients with clinically confirmed, localised disease at baseline in a large prospective clinical trial

Rationale. Prostate Cancer (PCa) is a leading cause of male mortality, with 336,000 deaths worldwide each year (1). Although most PCa cases are indolent, slow-growing, and tend not to progress, a subset of PCa cases are more aggressive and will progress to metastases, treatment resistance and death. Read more

Metabolism and prostate cancer plasticity

We are Helmholtz Munich. In a rapidly changing world, we discover breakthrough solutions for better health. Our research is focused within the areas of metabolic health/diabetes, environmental health, molecular targets and therapies, cell programming and repair, bioengineering, and computational health. Read more

Circadian rhythm effects on radiotherapy for prostate and other cancers

  Research Group: Human & Medical Genetics
Radiotherapy is used to treat more than 50% of cancer patients, but up to a quarter of patients suffer side effects that can affect their quality of life in the long-term. Read more

PhD studentship in health economics – cost effectiveness modelling of women’s cancer prevention strategies including BRCA testing for the Jewish population.

Queen Mary University London in collaboration with The London School of Hygiene & Tropical Medicine are pleased to invite applications for a PhD studentship in health economics, on cost effectiveness modelling of BRCA testing for the Jewish population and women’s cancer prevention. Read more

Estimating the global cancer burden due to low levels of physical activity

Rationale. Around 40% of all cancers are thought to be avoidable by modification of lifestyle factors. Obesity has been found to be a risk factor for several cancers and was estimated to have caused around 3.6% of all new cancers which occurred in 2012. Read more

Designing and evaluating novel nanotherapeutics to enhance the effectiveness of radiotherapy in the treatment of solid cancers.

One in two cancer patients will receive radiotherapy as part of their treatment. For patients with a localised cancer diagnosis effective radiotherapy represents the best chance of a curative outcome, however, is not without risk. Read more

Repurposing and enriching cardiovascular risk prediction model to identify people at risk of cancer – UCL (part of Health Data Research UK’s Big Data for Complex Disease Driver Programme)

Risk-stratified management of cardiovascular disease (CVD), where people without established disease receive preventative interventions and monitoring based on their 10-years predicted risk, has been highly successful to ensure healthcare resources are allocated to those most likely to benefit. Read more

Characterisation of tissue microstructure from non-invasive MRI using Machine Learning

The characterisation of biological tissue microstructure in vivo and non-invasively is of outmost interest in science. If successful, it could reveal unique insights into biological processes, including aging and cancer. Read more

Developing biodegradable long acting drug delivery systems for the treatment of chronic conditions

Non-adherence to treatment costs the NHS more than £500M each year. Adherence is especially important when treating patients with chronic conditions that require lifetime pharmacological treatment, such as schizophrenia, Parkinson’s disease, HIV and Alzheimer’s disease. Read more

Filtering Results